[DOI] [PubMed] [Google Scholar] 68.De Morais E.C., Stefanuto A., Klein G.A., Boaventura B.C., de Andrade F., Wazlawik E., di Pietro P.F., Maraschin M., da Silva E.L
Health Care Service Corporation (HCSC) corporate information Ozempic is FDA-approved for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D adults not for weight loss
Conclusion Hypothyroidism can result in many undesirable symptoms like dry skin, chronic fatigue, memory loss, high cholesterol, and an increased risk of heart disease
[9] Metformin Use Post-GLP-1 RA: Weight Maintenance Effect The post-GLP-1 RA period represents a significant clinical vulnerability
Safety notes: Generally well tolerated topically